Deficiency of CD36 in LECs highlights a new mechanism for the etiology of visceral obesity and insulin resistance, two phenotypes linked to the metabolic syndrome, which increases risk of cardiovascular disease and T2D, pathologies that associate with CD36 genetic variants66–68. Here, CD36 is linked to metabolic syndrome.